Target intelligence / Profile preview

Anopheles gambiae glutamate-gated chloride channel alpha 1 subunit (AgGluCl-a1) (AgGluCl-a1)

Target
AgGluCl-a1
Molecular classification
Ion channel, Cys-loop ligand-gated ion channel, Receptor
01

Overview

The Anopheles gambiae glutamate-gated chloride channel alpha 1 subunit (AgGluCl-a1) is a critical component of the inhibitory nervous system in the primary mosquito vector of malaria [1, 4]. As a member of the Cys-loop ligand-gated ion channel superfamily, it is found exclusively in invertebrates, making it a highly selective target for insecticidal agents [3, 5]. AgGluCl-a1 functions as a chloride-selective channel that is activated by the neurotransmitter glutamate, leading to membrane hyperpolarization and the suppression of neuronal activity [2, 4]. It is the primary molecular target of the avermectin class of drugs, such as ivermectin, which acts as a potent allosteric agonist [1, 10]. Binding of ivermectin to the transmembrane domain of AgGluCl-a1 causes persistent channel opening, resulting in flaccid paralysis and death of the mosquito [1, 4]. This target is central to innovative malaria control strategies, including mass drug administration of ivermectin to human populations to reduce the lifespan and transmission potential of biting mosquitoes [4, 5]. Resistance to insecticides targeting AgGluCl-a1 can occur through alternative splicing or specific mutations in the channel subunits, which alter drug sensitivity without compromising physiological function [3, 19].

Other names
AgGluClAgGluCl-alpha1Anopheles gambiae GluClGlutamate-gated chloride channel subunit alpha-1
02

Mechanism of action

Allosteric agonist (avermectins) or antagonist (fipronil) of the glutamate-gated chloride channel, leading to hyperpolarization and paralysis of the insect nervous system.

03

Biological functions

Inhibitory neurotransmissionChloride ion transportSignal transduction
04

Disease associations

InfectionMalaria
05

Safety considerations

Insecticide resistanceCross-reactivity with vertebrate Cys-loop receptors (e.g., GABA or glycine receptors) at high concentrations
06

Interacting drugs

Ivermectin

4 more in the full profile.

07

Biomarkers

GluCl gene mutations (resistance marker)

Beyond the preview

Go deeper on Anopheles gambiae glutamate-gated chloride channel alpha 1 subunit (AgGluCl-a1) (AgGluCl-a1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anopheles gambiae glutamate-gated chloride channel alpha 1 subunit (AgGluCl-a1) (AgGluCl-a1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call